Gene · 84649
Papers1,612
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,612
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis. | Metabol Open | 2024 | 38187470 | PubTator, text mining | PubMed |
| Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‑alcoholic fatty liver disease. | Int J Mol Med | 2024 | 38186319 | PubTator, text mining | PubMed |
| Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian Randomisation study. | EBioMedicine | 2024 | 38181703 | PubTator, text mining | PubMed |
| Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma. | J Cancer | 2024 | 38169540 | PubTator, text mining | PubMed |
| Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use. | Nat Commun | 2024 | 38167725 | PubTator, text mining | PubMed |
| Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. | Nat Commun | 2024 | 38167301 | PubTator, text mining | PubMed |
| Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways. | Mol Pharmacol | 2024 | 38164582 | PubTator, text mining | PubMed |
| Metabolic characteristics of granulosa cell tumor: role of PPARγ signaling†. | Biol Reprod | 2024 | 38123510 | PubTator, text mining | PubMed |
| Effects of (-)-epicatechin on hepatic triglyceride metabolism. | Food Funct | 2024 | 38086683 | PubTator, text mining | PubMed |
| A missense variant in human perilipin 2 (PLIN2 Ser251Pro) reduces hepatic steatosis in mice. | JHEP Rep | 2024 | 38074507 | PubTator, text mining | PubMed |
| Esculetin unveiled: Decoding its anti-tumor potential through molecular mechanisms-A comprehensive review. | Cancer Rep (Hoboken) | 2024 | 38062981 | PubTator, text mining | PubMed |
| Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway. | Eur J Pharmacol | 2024 | 38006926 | PubTator, text mining | PubMed |
| Genetic Ablation of C/EBPα-p300 Pathway Blocks Development of Obese Pregnancy Associated Liver Disorders in Offspring. | Cell Mol Gastroenterol Hepatol | 2024 | 37967813 | PubTator, text mining | PubMed |
| LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers. | Adv Sci (Weinh) | 2024 | 37939296 | PubTator, text mining | PubMed |
| Identification of SGMS2 as a molecule involved in natural killer cell recruitment and its in-deep analysis in the liver cancer microenvironment: Evidence from large populations cohort. | J Gene Med | 2024 | 37849429 | PubTator, text mining | PubMed |
| TOP1MT affects lipid metabolism of colorectal cancer via regulating the expression of DGAT2. | Asian J Surg | 2024 | 37805317 | PubTator, text mining | PubMed |
| DNMT3B Alleviates Liver Steatosis Induced by Chronic Low-grade LPS via Inhibiting CIDEA Expression. | Cell Mol Gastroenterol Hepatol | 2024 | 37703946 | PubTator, text mining | PubMed |
| Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). | Metabolites | 2023 | 38248815 | PubTator, text mining | PubMed |
| Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties. | Plants (Basel) | 2023 | 38202328 | PubTator, text mining | PubMed |
| [miR-23b-3p regulates the differentiation of goat intramuscular preadipocytes by targeting the PDE4B gene]. | Sheng Wu Gong Cheng Xue Bao | 2023 | 38147989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84649/papers?page=7